Category: biotech

.AstraZeneca has made use of artificial intelligence to create a distinct biomarker for its Daiichi Sankyo-partnered datopotamab deruxtecan (Dato-DXd), intending to vary the antibody-drug conjugate

.AN2 Therapies is reassessing its business in feedback to lackluster midphase information, promising to give up half its own staff members and stop a stage

.ALX Oncology’s stage 2 gastric cancer cells action fee has weakened. After finding its own CD47 blocker quickly beat control over the first one-half of

.After greater than twenty years of service neurodegenerative diseases, Swiss biotech a/c Immune system cases it can possess an activity changer on its hands.The firm’s